• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of Nusinersen treatment on motor functions in children and adolescents with spinal muscular atrophy who gave a break to physiotherapy during COVID-19 pandemic.

作者信息

Öztürk Gülten, Karadağ Saygı Evrim, Ünver Olcay, Türkdoğan Dilşad

机构信息

Department of Pediatric Neurology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.

Department of Physical Medicine and Rehabilitation, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.

出版信息

Turk J Phys Med Rehabil. 2022 Mar 1;68(1):157-158. doi: 10.5606/tftrd.2022.9105. eCollection 2022 Mar.

DOI:10.5606/tftrd.2022.9105
PMID:35949963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9305651/
Abstract
摘要

相似文献

1
Effect of Nusinersen treatment on motor functions in children and adolescents with spinal muscular atrophy who gave a break to physiotherapy during COVID-19 pandemic.在2019年冠状病毒病大流行期间中断物理治疗的脊髓性肌萎缩症儿童和青少年中，诺西那生治疗对其运动功能的影响。
Turk J Phys Med Rehabil. 2022 Mar 1;68(1):157-158. doi: 10.5606/tftrd.2022.9105. eCollection 2022 Mar.
2
Nusinersen treatment of older children and adults with spinal muscular atrophy.依地膦酸治疗骨质疏松症的研究进展
Neuromuscul Disord. 2021 Mar;31(3):183-193. doi: 10.1016/j.nmd.2020.12.006. Epub 2020 Dec 20.
3
Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?2019年冠状病毒病大流行对接受诺西那生治疗的脊髓性肌萎缩症患儿的影响：失去了什么，又获得了什么？
Front Neurol. 2021 Sep 21;12:704928. doi: 10.3389/fneur.2021.704928. eCollection 2021.
4
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.用nusinersen 治疗婴儿型脊肌萎缩症：一项 2 期、开放标签、剂量递增研究。
Lancet. 2016 Dec 17;388(10063):3017-3026. doi: 10.1016/S0140-6736(16)31408-8. Epub 2016 Dec 7.
5
Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: Real world data from Hungarian patients.依库珠单抗治疗 1、2 和 3 型脊髓性肌萎缩症的疗效：来自匈牙利患者的真实世界数据。
Eur J Paediatr Neurol. 2020 Jul;27:37-42. doi: 10.1016/j.ejpn.2020.05.002. Epub 2020 May 14.
6
Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review.目前使用 nusinersen 治疗脊髓性肌萎缩症的证据：系统评价。
Acta Neurol Belg. 2019 Dec;119(4):523-533. doi: 10.1007/s13760-019-01199-z. Epub 2019 Aug 6.
7
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study.用nusinersen 治疗婴儿型脊肌萎缩症：2 期、开放标签、多中心、剂量递增研究的最终报告。
Lancet Child Adolesc Health. 2021 Jul;5(7):491-500. doi: 10.1016/S2352-4642(21)00100-0. Epub 2021 Jun 3.
8
A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.鞘内注射诺西那生治疗脊髓性肌萎缩症的综合机构概述。
Pediatr Radiol. 2018 Nov;48(12):1797-1805. doi: 10.1007/s00247-018-4206-9. Epub 2018 Jul 18.
9
Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study.用onasemnogene abeparvovec 基因替换疗法治疗年龄在 24 个月或以下且体重不超过 15 公斤的脊髓性肌萎缩症儿童：一项观察性队列研究。
Lancet Child Adolesc Health. 2022 Jan;6(1):17-27. doi: 10.1016/S2352-4642(21)00287-X. Epub 2021 Oct 29.
10
Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen.经 nusinersen 治疗的脊髓性肌萎缩症患儿的轴突兴奋性变化。
J Physiol. 2022 Jan;600(1):95-109. doi: 10.1113/JP282249. Epub 2021 Dec 3.

本文引用的文献

1
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study.依库珠单抗治疗脊髓性肌萎缩症的安全性和有效性：EMBRACE 研究。
Muscle Nerve. 2021 May;63(5):668-677. doi: 10.1002/mus.27187. Epub 2021 Feb 16.
2
COVID-19 in children with neuromuscular disorders.儿童神经肌肉疾病与 COVID-19。
J Neurol. 2021 Sep;268(9):3081-3085. doi: 10.1007/s00415-020-10339-y. Epub 2021 Jan 2.
3
Neuromuscular Diseases Care in the Era of COVID-19.新冠疫情时代的神经肌肉疾病护理
Front Neurol. 2020 Nov 26;11:588929. doi: 10.3389/fneur.2020.588929. eCollection 2020.
4
Spinal muscular atrophy care in the COVID-19 pandemic era.COVID-19 大流行时期的脊髓性肌萎缩症护理。
Muscle Nerve. 2020 Jul;62(1):46-49. doi: 10.1002/mus.26903. Epub 2020 May 3.
5
COVID-19 and neuromuscular disorders.新型冠状病毒肺炎与神经肌肉疾病。
Neurology. 2020 Jun 2;94(22):959-969. doi: 10.1212/WNL.0000000000009566. Epub 2020 Apr 13.